CAS: 175414-77-4 - (+)-7-[3(S)-Methoxy-4(S)-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(2-thiazolyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
Formula:C18H19N5O4S
InChI:InChI=1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1
InChI key:InChIKey=XZAFZXJXZHRNAQ-STQMWFEESA-N
SMILES:O=C(O)C1=CN(C2=NC=CS2)C3=NC(=CC=C3C1=O)N4CC(OC)C(NC)C4
- Synonyms:
- 1,4-Dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
- 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-
- 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-, (3S-trans)-
- Ag-7352
- Sns-595
- Spc-595
- Voreloxin
- Vosaroxin
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-
CAS:175414-77-4
Formula:
C18H19N5O4S
Color and Shape:
Solid
Molecular weight:
401.4396
Ref: IN-DA0020Z6
1mg | 159.00 € | ||
5mg | 314.00 € | ||
10mg | 645.00 € | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Voreloxin
CAS:175414-77-4
Voreloxin (SNS-595) is a potent Topoisomerase II inhibitor with broad-spectrum anti-tumor activity. Phase 2.
Formula:
C18H19N5O4S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
401.44
Ref: TM-T6724
1mg | 121.00 € | ||
5mg | 370.00 € | ||
25mg | 1,404.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Voreloxin
CAS:175414-77-4
Voreloxin is a topoisomerase inhibitor that binds to the enzyme's active site, preventing it from …
Formula:
C18H19N5O4S
Purity:
Min. 95%
Molecular weight:
401.44 g/mol
Ref: 3D-AHA41477
1mg | 188.00 € | ||
2mg | 300.00 € | ||
5mg | 470.00 € | ||
10mg | 704.00 € | ||
25mg | 1,052.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024